Publications by authors named "Weylandt K"

Evidence suggests beneficial effects of long-chain n-3 polyunsaturated fatty acids (PUFAs) in inflammatory diseases. However, the underlying mechanisms are still subject of research. For this purpose, we developed an ex vivo n-3 PUFA supplementation strategy.

View Article and Find Full Text PDF

Introduction: Previous studies have indicated that activity of fatty acid desaturase 1 (FADS1), is involved in cardiometabolic risk. Recent experimental data have shown that FADS1 knockdown can promote lipid accumulation and lipid droplet formation in liver cells. In this study, we aimed to characterize whether different FADS1 genotypes affect liver fat content, essential fatty acid content and free oxylipin mediators in the blood.

View Article and Find Full Text PDF

Unlabelled: Long-chain -3 polyunsaturated fatty acid (PUFA) supplementation has shown potential benefits in the prevention of coronary heart disease (CHD); however, the impact of omega-3 fatty acid levels on CHD risk remains a subject of debate. Here, we aimed to investigate the association between -3 PUFA levels and the risk of CHD, with particular reference to the subtypes of -3 PUFA.

Methods: Prospective studies and retrospective case-control studies analyzing -3 PUFA levels in CHD, published up to 30 July 2022, were selected.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical cancer registries aim to provide accurate data analysis and identify ways to enhance care in oncology, focusing on distinct cancer types.
  • A study of the Clinical Epidemiological Cancer Registry Brandenburg-Berlin from 2000 to 2018 revealed that squamous cell carcinoma (ESCC) was more prevalent than adenocarcinoma (EAC), although EAC cases are rising, especially among men.
  • Treatment primarily relied on chemotherapy and radiotherapy, with surgery rates at 19% for ESCC and 42% for EAC, raising concerns about the low surgical intervention despite the quality being comparable to international standards.
View Article and Find Full Text PDF
Article Synopsis
  • - Colorectal cancer (CRC) is a common and seriously impactful cancer, with increasing cases linked to Western lifestyle factors like diet, particularly high omega-6 and low omega-3 fatty acids, which contribute to inflammation and cancer progression.
  • - Oxylipins, which are bioactive lipids produced from PUFAs, play significant roles in CRC by influencing inflammation and cellular growth, with particular focus on those derived from omega-6 fatty acids.
  • - The review discusses how understanding the metabolism of PUFAs and their related oxylipins can lead to new strategies for enhancing cancer immunotherapy and potential prevention methods for CRC.
View Article and Find Full Text PDF

Background And Aims: Previous studies have shown that lipoprotein apheresis can modify the plasma lipidome and pro-inflammatory and pro-thrombotic lipid mediators. This has not been examined for treatment with protein convertase subtilisin/kexin type 9 inhibitors such as evolocumab, which are increasingly used instead of lipoprotein apheresis in treatment-resistant familial hypercholesterolemia. The aim of this study was to compare the effects of evolocumab treatment and lipoprotein apheresis on the fatty acid profile and on formation of lipid mediators in blood samples.

View Article and Find Full Text PDF

The ketogenic diet (KD) is a high-fat, low-carbohydrate diet that has been reported to have neuroprotective effects. The health effects of KD might be linked to an altered gut microbiome, which plays a major role in host health, leading to neuroprotective effects via the gut-brain axis. However, results from different studies, most often based on the 16S rRNA gene and metagenome sequencing, have been inconsistent.

View Article and Find Full Text PDF

Objective: Dyslipidemia, in particular elevated triglycerides (TGs) contribute to increased cardiovascular risk in type 2 diabetes mellitus (T2DM). In this pilot study we aimed to assess how increased TGs affect hepatic fat as well as polyunsaturated fatty acid (PUFA) metabolism and oxylipin formation in T2DM patients.

Methods: 40 patients with T2DM were characterized analyzing routine lipid blood parameters, as well as medical history and clinical characteristics.

View Article and Find Full Text PDF

Background, Objectives And Design: Arachidonic acid 15-lipoxygenase (ALOX15) has been implicated in the pathogenesis of inflammatory diseases but since pro- and anti-inflammatory roles have been suggested, the precise function of this enzyme is still a matter of discussion. To contribute to this discussion, we created transgenic mice, which express human ALOX15 under the control of the activating protein 2 promoter (aP2-ALOX15 mice) and compared the sensitivity of these gain-of-function animals in two independent mouse inflammation models with Alox15-deficient mice (loss-of-function animals) and wildtype control animals.

Materials And Methods: Transgenic aP2-ALOX15 mice were tested in comparison with Alox15 knockout mice (Alox15) and corresponding wildtype control animals (C57BL/6J) in the complete Freund's adjuvant induced hind-paw edema model and in the dextran sulfate sodium induced colitis (DSS-colitis) model.

View Article and Find Full Text PDF
Article Synopsis
  • Inflammatory bowel disease (IBD) can lead to liver inflammation, and dietary intake of omega-3 polyunsaturated fatty acids (n-3 PUFA) may help reduce the severity of IBD.
  • A study using a mouse model showed that mice with higher levels of n-3 PUFA had less colitis-induced liver inflammation and oxidative damage compared to normal mice.
  • The benefits were linked to increased production of specific anti-inflammatory compounds derived from n-3 PUFA, suggesting that these fatty acids play a protective role in managing liver inflammation associated with IBD.
View Article and Find Full Text PDF

The seeds of (horseradish tree) contain about 40% of one of the most stable vegetable oils (Moringa seed oil). Therefore, the effects of Moringa seed oil on human SZ95 sebocytes were investigated and were compared with other vegetable oils. Immortalized human SZ95 sebocytes were treated with Moringa seed oil, olive oil, sunflower oil, linoleic acid and oleic acid.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is a leading cause of cancer death, and medical treatment options are limited. The multikinase inhibitor sorafenib was the first approved drug widely used for systemic therapy in advanced HCC. Sorafenib might affect polyunsaturated fatty acids (PUFA)-derived epoxygenated metabolite levels, as it is also a potent inhibitor of the soluble epoxide hydrolase (sEH), which catalyzes the conversion of cytochrome-P450 (CYP)-derived epoxide metabolites derived from PUFA, such as omega-6 arachidonic acid (AA) and omega-3 docosahexaenoic acid (DHA), into their corresponding dihydroxy metabolites.

View Article and Find Full Text PDF

Adoptive cell therapy (ACT) using specific immune cells and stem cells has emerged as a promising treatment option that could complement traditional cancer therapies in the future. In particular, tumor-infiltrating lymphocytes (TILs) have been shown to be effective against solid tumors in various clinical trials. Despite the enormous disease burden and large number of premature deaths caused by colorectal cancer (CRC), studies on TILs isolated from tumor tissue of patients with CRC are still rare.

View Article and Find Full Text PDF
Article Synopsis
  • Long-term parenteral nutrition can cause liver disease in patients, but omega-3 fatty acids like EPA and DHA may help prevent this condition.* -
  • In a study with 8 patients, researchers observed changes in fatty acid profiles and metabolites after adding fish oil to parenteral nutrition for 8 weeks, which significantly increased omega-3 levels.* -
  • The results showed that fish oil primarily increases inflammation-reducing compounds from EPA and DHA without causing significant changes in inflammation or liver function over the short study period.*
View Article and Find Full Text PDF

Background: The effect of omega-3 polyunsaturated fatty acids (n-3 PUFAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on cardiovascular risk modification in type 2 diabetes and related complications remain unclear. We aim to assess the published effects of n-3 PUFA interventions on lipid risk factors in type 2 diabetes.

Methods: We searched the literature on Pubmed, Embase, CENTRAL, and Web of Science databases in order to perform a pooled analysis of randomized clinical trials (RCTs) assessing n-3 PUFA interventions in type 2 diabetes.

View Article and Find Full Text PDF

Objective: We investigated the relationships between interleukin- (IL-) 1 and IL-1 receptor antagonist (IL-1Ra) gene polymorphism and plasma levels in patients with diabetic nephropathy (DN).

Methods: The genotype and allele frequency distribution of IL-1 and IL-1Ra in 61 patients with DN and 48 healthy controls (HCs) were determined by kompetitive allele-specific PCR (KASP), and the plasma concentrations of IL-1 and IL-1Ra in DN patients and HCs were measured by enzyme-linked immunosorbent assays (ELISA).

Results: Significant differences were detected in the distribution of IL-1 (-511C/T) genotype and allele frequencies between the DN and HC groups ( < 0.

View Article and Find Full Text PDF
Article Synopsis
  • Specialized pro-resolving lipid mediators (SPMs), like lipoxins and resolvins, are formed from arachidonic acid through various lipoxygenase enzymes, but their levels are typically much lower than common pro-inflammatory mediators, making them difficult to detect.
  • The paper evaluates the biochemical pathways for SPM formation, their receptors, and methods for quantifying these mediators, highlighting issues such as low biosynthetic capacity and lack of validation for current receptor signaling.
  • Key findings suggest that SPM levels in humans are not directly related to dietary omega-3 fatty acids or the resolution of inflammation, raising doubts about their effectiveness as natural regulators of inflammation.
View Article and Find Full Text PDF
Article Synopsis
  • Coronary artery disease (CAD) is the top cause of death globally, but treatments like statins can help reduce its health risks.
  • This study examined the fat composition in the blood of 273 patients to see how levels of omega-3 and omega-6 fatty acids are related to CAD occurrence.
  • Findings showed that CAD patients had higher levels of certain fatty acid ratios that indicate an increase in arachidonic acid and significantly lower omega-3s like eicosapentaenoic acid (EPA), suggesting that higher EPA levels could provide heart protection.
View Article and Find Full Text PDF

Background: Men and women with valvular heart disease have different risk profiles for clinical endpoints. Non-esterified fatty acids (NEFA) are possibly involved in cardio-metabolic disease. However, it is unclear whether NEFA concentrations are associated with physical performance in patients undergoing transcatheter aortic valve implantation (TAVI) and whether there are sex-specific effects.

View Article and Find Full Text PDF

Background: Pancreatic cancer is the second most frequent cause of death among all forms of cancer in Germany with more than 19,000 deaths per year. The evaluation of the nationwide clinical cancer register aims to depict the reality of treatment and to improve the quality of treatment in the future by targeted analyses.

Method: The data from the clinical cancer register of Brandenburg-Berlin for the diagnosis years 2001-2017 were analyzed with respect to the treatment of pancreatic cancer.

View Article and Find Full Text PDF

Arachidonic acid 5-lipoxygenase (ALOX5) is the key enzyme in the biosynthesis of pro-inflammatory leukotrienes. We recently created knock-in mice (-KI) which express an arachidonic acid 15-lipoxygenating Alox5 mutant instead of the 5-lipoxygenating wildtype enzyme. These mice were leukotriene deficient but exhibited an elevated linoleic acid oxygenase activity.

View Article and Find Full Text PDF

The  reference single-nucleotide polymorphism rs738409 has been identified as a predisposing factor for nonalcoholic fatty liver disease. A simple method based on PCR and restriction fragment length polymorphism (RFLP) analysis had been published to detect the nonpathogenic allele  rs738409 variant. The presence of the pathogenic variant was deduced by the indigestibility of the corresponding PCR product with CI recognizing the nonpathogenic allele.

View Article and Find Full Text PDF

(1) Background: Healthcare workers (HCWs) are prone to intensified exposure to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in the ongoing pandemic. We prospectively analyzed the prevalence of antibodies against SARS-CoV-2 in HCWs at baseline and follow up with regard to clinical signs and symptoms in two university hospitals in Brandenburg, Germany. (2) Methods: Screening for anti-SARS-CoV-2 IgA and IgG antibodies was offered to HCWs at baseline and follow up two months thereafter in two hospitals of Brandenburg Medical School during the first wave of the COVID-19 pandemic in Germany in an ongoing observational cohort study.

View Article and Find Full Text PDF

Objective: Cyclooxygenase (COX)-derived prostaglandin E (PGE) is an important lipid mediator in colorectal carcinoma (CRC) pathogenesis. Other lipid mediators derived from lipoxygenases (LOX) have also been implicated in neoplastic processes in the colon. In this study we aimed to characterize lipid mediators, so called oxylipins, in human colon adenomatous polyps.

View Article and Find Full Text PDF